Myria Galazi

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

David J. Pinato, Alberto Zambelli, Mark Bower et al. · Cancer Discovery · 2020 · 183 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Mark Bower, Lorenza Scotti et al. · The Lancet Oncology · 2021 · 136 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

David J. Pinato, Daniela Ferrante, Georgina Hanbury et al. · The Lancet Oncology · 2022 · 80 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe

David J. Pinato, Alvin Lee, Federica Biello et al. · Cancers · 2020 · 65 citations · Full text

Medicine, Infectious Diseases, Oncology +13